Urinalysis market is expected to exibhit a growth of 7.5% CAGR during the forecast period. The higher burden of chronic diseases and rising adaptation of point of care testing is expected to be the major contributing factors for the market growth. Urinary tract infection refers to the infection in any part of the urinary system. According to the Therapeutic Advances in Urology, urinary tract infections are commonly found in the women with a global incidence of around 50% - 60% in adult women, in 2019. Furthermore, according to the study of Parasites and Vectors, 2019, which evaluated the Clinitek (manufactured by Siemens Healthineers) for its efficacy. Clinitek is a point-of-care testing that automatically checks the humidity exposure and other parameters. The results for this evaluation was observed that the device was enable to successfully detect the haematuria and nitrites. Hence, these factors are expected to fuel the growth of urinalysis market.
Key Market Trends Automated Analysers Segment is Expected to Hold a Major Market Share in the Market
Automated analyzers segment is expected to hold a major market share in the urinalysis treatment owing to technological advancments in the product. For instance, in 2018, Beckman Coulter and Arkray Inc. patnered to develop iQ Urinalysis Workcell for urinalysis testing. It involves a morphology imaging system and a automated analyzer. Furthermore, according to the study published, in 2019, by Journal of Clinical Laboratory Analysis, the automated analyzers were found to be more efficient and effective for urinalysis.
Also, higher prevalence of diabetes is expected to boost up the demand for automated analyzers. According to International Diabetes Federation, in 2019, around 429.9 million people were diagnosed with diabetes. Hence, aforementioned factors are expected to propel the urinalysis market grwoth.
North America is Expected to Hold a Significant Share in the Market
North America is expected to hold a major market share in the global urinalysis market due to increasing aging population and higher prevalence of chronic kidney diseases. Chronic kidney disease is associated with the kidney failure. According to National Kidney Foundation, chronic kidney disease causes more death than breast cancer and prostate cancer. Currently, around 37 million people are affected with it. It is more prevalent in older population, affecting approximately 15% of the adult population. Hence, this emerges the need for proper diagnosis and treatment of chronic kidney diseases and thereby these factors are expected to boost the demand for urinalysis market.
Competitive Landscape Companies are taking strategic initiatives to grow their presence in the urinalysis market. For instance, in 2016, Sysmex launched UD-10 Fully-Automated Imaging for testing of sediment urinalysis. Currently the market is dominated by few players such as Cardinal Health Inc., Alere (Abbott Laboratories), Beckman Coulter Inc., Siemens Healthineers, Roche Diagnostics, Sysmex Corporation, Bio-Rad Laboratories Inc., Arkray Inc., Acon Laboratories Inc., and Becton, Dickinson and Company.
Reasons to Purchase this report: - The market estimate (ME) sheet in Excel format - 3 months of analyst support
Our reports have been used by over 10K customers, including:
Executive Summary The Global Injectable Drugs Market was valued at USD 414.88 Billion in the year 2020. Increasing prevalence of diseases such as diabetes, cancer and auto-immune disorders like rheumatoid arthritis and multiple sclerosis with an upsurge in the number of chronic diseases have driven the need for drug delivery...
256 pages •
By The Business Research Company
• Mar 2021
Non-Contact Infrared Thermometers Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global non-contact infrared thermometers market as it emerges from the COVID 19 shut down. Description: Where...
The market is primarily driven by the growing prevalence of chronic diseases such as diabetes, respiratory diseases and cancer. Furthermore, the growing geriatric population and technological advances in drug delivery systems is projected to boost market growth over the forecast period. Moreover, expanding applications of drug device combination...
The Middle East and Africa Artificial Intelligence (AI) in healthcare market is expected to reach US$ 5,713.28 million by 2027 from US$ 222.03 million in 2019; it is estimated to grow at a CAGR of 48.8% from 2020 to 2027. The growth of the market is attributed to the driving factors such as rising application of artificial intelligence (AI)...
296 pages •
By The Business Research Company
• Mar 2021
Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Opportunities And Strategies To 2030: COVID 19 Impact And Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global vascular endothelial growth factor (VEGF) inhibitor market. Description: Where...
Executive Summary Global Nucleic Acid Isolation and Purification Market was valued at USD 3359.84 Million in the year 2020. The growth of this market can majorly be attributed to the increasing R&D activities as well as technological advancements and increasing automation. However, the high cost of automated instruments...
Increase in prevalence of heart diseases worldwide is the primary factor driving the electrocardiograph (ECG) market globally. According to the WHO, cardiovascular disease is one of the leading cause of death worldwide. It is estimated that cardiovascular diseases (CVDs) take the lives of 17.9 million people every year, 31% of all global deaths....
The global medical engineered materials market size is projected to reach USD 29.1 billion by 2025 from USD 15.8 billion in 2020, at a CAGR of 13.0%. This growth is attributed to the increasing healthcare expenses in emerging economies, and rising geriatric population increasing need of advanced medical technologies and devices. Also, innovations...
The stem cell market was valued at USD 14.7 billion in 2020, and it is expected to reach approximately USD 26.40 billion in 2026, registering a CAGR of nearly 10.24% during the forecast period, 2021-2026. The growth of the market is attributed to the rising number of clinical trials and the growing adoption of stem cell therapies globally....
The Vascular Embolization market was valued at approximately USD 1,381.20 million in 2020 and is expected to witness a revenue of USD 2,375.14 million in 2026, with a CAGR of 9.50% over the forecast period. The outbreak of COVID-19 impacted the vascular embolization market, as hospitals and healthcare services for non-covid indications...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.